Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,93 USD | +6,62% | +5,96% | +17,86% |
26/02 | COGENT BIOSCIENCES, INC. : Citigroup herhaalt koopadvies | ZM |
26/02 | Cogent Biosciences, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 164
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Robbins
CEO | Chief Executive Officer | 48 | 23-10-20 |
John Green
DFI | Director of Finance/CFO | 43 | 01-06-18 |
Rachael Easton
CTO | Chief Tech/Sci/R&D Officer | - | 28-11-22 |
Brad Barnett
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jessica Sachs
CTO | Chief Tech/Sci/R&D Officer | 49 | 01-04-17 |
John Robinson
CTO | Chief Tech/Sci/R&D Officer | 50 | 06-04-21 |
Christi Waarich
IRC | Investor Relations Contact | - | - |
Dana Martin
PRN | Corporate Officer/Principal | - | 01-11-21 |
Sara Saltzman
LAW | General Counsel | - | 01-01-19 |
Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 26-07-19 |
Matthew Ros
BRD | Director/Board Member | 57 | 26-07-19 |
Todd Shegog
BRD | Director/Board Member | 59 | 22-02-21 |
Karen Ferrante
BRD | Director/Board Member | 66 | 01-02-18 |
Andrew Robbins
CEO | Chief Executive Officer | 48 | 23-10-20 |
Peter Harwin
CHM | Chairman | 38 | 06-07-20 |
Chris Cain
BRD | Director/Board Member | 40 | 06-07-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 95 613 396 | 94 354 142 ( 98,68 %) | 0 | 98,68 % |
Aandeel B | 0 | 74 465 | 0 | 0 |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,86% | 663 mln. | |
-1,17% | 104 mld. | |
+2,87% | 97,47 mld. | |
+3,84% | 22,25 mld. | |
-14,77% | 21,68 mld. | |
-9,14% | 18,2 mld. | |
-39,98% | 17,02 mld. | |
-13,21% | 16,36 mld. | |
+8,55% | 14,39 mld. | |
+35,75% | 12,37 mld. |
- Beurs
- Aandelen
- Koers COGT
- Onderneming Cogent Biosciences, Inc.